Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

70.69
BATS BZX Real-Time Price
As of 1:42pm ET
 +0.20 / +0.28%
Today’s Change
37.35
Today|||52-Week Range
75.98
+82.66%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.2B

Company Description

Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company. It discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale on January, 1992 and is headquartered in San Diego, CA.

Contact Information

Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego California 92130
P:(858) 617-7600
Investor Relations:

Employees

Shareholders

Individual stakeholders8.63%
Mutual fund holders75.90%
Other institutional34.59%

Top Executives

Kevin Charles GormanChief Executive Officer & Director
Matthew C. AbernethyChief Financial Officer
Dimitri E. GrigoriadisChief Research Officer
Bill WilsonVice President-Information Technology & Operations
Christopher Flint O'BrienChief Medical Officer